Healthcare

25 Apr 2022  |  North America

Frost Radar™: Artificial Intelligence-enabled Drug Discovery, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

Pharmaceutical drug discovery and development has been suffering from declining success rates with new molecules primarily because of poor external validity of preclinical models and lack of efficacy of the molecule in terms of the intended disease indication. Drug success rates continue to be in the range of only 1 in 10 that enters clinical phase...

The North American and European multi-vendor services (MVS) market is expected to witness significant changes over the next couple of years, driven by the increasing adoption of technology by both MVS providers and healthcare facilities, the shift from inpatient to outpatient settings for surgical procedures, and the rising use of medical equipment...

The global medical imaging and informatics market is experiencing significant changes with the emergence of advanced technologies, the changing consumer landscape and priorities, consolidation among radiology practices, mergers and acquisitions, portability, regulatory and reimbursement changes, smart manufacturing, local and global manufacturing, ...

As the healthcare industry continues adjusting to the increasing diagnosis of lifestyle-related diseases and demand for affordable care, effective surgical procedures assisted by robotic devices and a decline in treatment costs look promising. Next-generation surgical robotic technology platforms complement and extend surgeons’ ability to minimiz...

Clinical documentation improvement (CDI), a vital mechanism in documenting care in the healthcare space, is a strategic necessity that goes beyond a component in the broader revenue cycle management (RCM) of claims processing. It focuses on improved patient outcomes, supports data quality that tells an accurate story of the patient’s care, facili...

Digital health offered extensive support and grew stronger as the pandemic continued with several variants across the globe. Telehealth and other enterprise IT solutions continued to be the backbone for healthcare systems, and access to health in the hands of the patients empowered consumers to manage their health with the best of tools. As the dem...

In vitro diagnostics introduces new technologies, sequencing methods, novel software algorithms, and multi-omics approaches to realise the goal of personalized medicine. Next-generation diagnostics has been the backbone of COVID-19-related emergency diagnosis, with an estimated 25% to 30% of revenue during 2020 and early 2021 related to this testin...

11 Mar 2022  |  North America

Global Medical Devices Outlook, 2022

Digital Efficiency Solutions for Operating Rooms and Competitive Intensity are Opening up New Growth Opportunities

Infographics

×

As the healthcare sector adapts to the changes induced by the COVID-19 pandemic, the global medical devices industry is undergoing a major transformation in terms of business models, technology adoption, and care delivery approaches, among other areas. 2022 will prove to be another challenging year for medtech as uncertainties pertaining to COVID-1...

08 Mar 2022  |  North America

Global Pharmaceuticals Outlook, 2022

The Digitalization of the Pharmaceuticals Value Chain is Opening up New Growth Opportunities for Stakeholders

Infographics

×

Key Issues Addressed

Frost & Sullivan offers an outlook for the global pharmaceuticals market for 2022-2026, including emerging trends and growth opportunities. Prioritizing booster doses over initial dose coverage is negatively impacting the global mitigation of the COVID-19 pandemic, which is resulting in severe implications on health and social and economic well-bei...